Researchers have discovered that the neurotransmitter adenosine effectively acts as a brake to dopamine, another well-known neurotransmitter involved in motor control. The discovery could immediately suggest new avenues of drug development to treat symptoms of Parkinson's disease, a movement disorder where the loss of dopamine-producing cells has been widely implicated as a cause.